http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0334177-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cab64dfbe7ad218bda5bdcddbc2bf326
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
filingDate 1989-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3506e09f44923084b294a18fa0739b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0405d02d89cb820d094be7ca04b1132e
publicationDate 1989-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0334177-A2
titleOfInvention Pharmaceutical product for oral administration, particularly for the iron and magnesium substitution therapy
abstract The invention relates to an orally administrable pharmaceutical agent, which is particularly suitable for iron and magnesium replacement therapy. This agent consists of a combination of one or more pharmaceutically and physiologically tolerable iron compound (s), one or more pharmaceutically and physiologically tolerable magnesium compound (s) and, if the magnesium compound (s) does not contain any available chlorine atoms which saturate the available magnesium valences and are dissociable in aqueous media (Contain), one or more pharmaceutically and physiologically compatible compound (s) providing chlorine ions in aqueous media together with conventional pharmaceutical solvents and / or diluents and / or auxiliaries.n n n With this agent, it is surprisingly possible to simultaneously administer magnesium and optionally calcium compounds together with iron compounds without reducing iron absorption.
priorityDate 1988-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-294891-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0061175-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88433046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234666439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127470435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID754

Total number of triples: 21.